Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for PCRX

Stock NamePacira BioSciences, Inc.
TickerPCRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS6951271005

Show aggregate PCRX holdings

News associated with PCRX

Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year target price […] - 2025-08-12 04:43:07
Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank
Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 20.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,519 shares of the company’s stock after buying an additional 2,848 shares during […] - 2025-08-08 04:56:50
Pacira BioSciences (NASDAQ:PCRX) Upgraded at Truist Financial
Truist Financial upgraded shares of Pacira BioSciences (NASDAQ:PCRX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday, MarketBeat.com reports. The brokerage currently has $30.00 target price on the stock. Other equities analysts also recently issued research reports about the stock. HC Wainwright upped their […] - 2025-07-28 04:18:52
Bank of New York Mellon Corp Has $9.60 Million Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Bank of New York Mellon Corp decreased its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 2.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 386,149 shares of the company’s stock after selling 10,250 shares during the period. Bank […] - 2025-07-22 06:22:51
Louisiana State Employees Retirement System Cuts Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Louisiana State Employees Retirement System lessened its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 2.7% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 21,700 shares of the company’s stock after selling 600 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Pacira […] - 2025-07-21 05:18:53
Illinois Municipal Retirement Fund Has $629,000 Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Illinois Municipal Retirement Fund grew its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 24.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,318 shares of the company’s stock after acquiring an additional 5,011 […] - 2025-07-03 05:13:03
Robeco Institutional Asset Management B.V. Purchases 12,750 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
Robeco Institutional Asset Management B.V. increased its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 18.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 82,694 shares of the company’s stock after buying an additional 12,750 shares during the quarter. Robeco […] - 2025-07-02 05:11:08
Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Average Recommendation of “Hold” by Brokerages
Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) have been assigned an average rating of “Hold” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating […] - 2025-06-18 05:08:55
Head to Head Analysis: Pacira BioSciences (NASDAQ:PCRX) versus I-Mab (NASDAQ:IMAB)
Pacira BioSciences (NASDAQ:PCRX – Get Free Report) and I-Mab (NASDAQ:IMAB – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings and analyst recommendations. Insider and Institutional Ownership 99.7% of Pacira BioSciences […] - 2025-06-18 03:08:45
California State Teachers Retirement System Has $812,000 Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
California State Teachers Retirement System lessened its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 1.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 43,123 shares of the company’s stock after selling 835 shares during the quarter. California State Teachers […] - 2025-06-11 05:02:51
Friday's ETF with Unusual Volume: XPH
The SPDR S&P Pharmaceuticals ETF is seeing unusually high volume in afternoon trading Friday, with over 318,000 shares traded versus three month average volume of about 57,000. Shares of XPH were up about 1.5% on the day. Components of that ETF with the highest volume on - 2025-06-06 13:49:47
Two Sigma Investments LP Acquires 45,222 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
Two Sigma Investments LP grew its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 65.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 114,682 shares of the company’s stock after buying an additional 45,222 shares during the quarter. Two Sigma Investments LP’s holdings in Pacira BioSciences were worth […] - 2025-06-02 05:08:57
State of Wyoming Boosts Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)
State of Wyoming lifted its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 8.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,566 shares of the company’s stock after purchasing an additional 487 shares during the quarter. State of Wyoming’s holdings […] - 2025-05-27 05:17:01
Graham Capital Management L.P. Sells 61,645 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
Graham Capital Management L.P. decreased its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 83.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,268 shares of the company’s stock after selling 61,645 shares during the period. Graham Capital Management […] - 2025-05-19 05:27:01
Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Voya Investment Management LLC
Voya Investment Management LLC lowered its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 68.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,948 shares of the company’s stock after selling 29,901 shares during the quarter. Voya Investment Management […] - 2025-05-13 05:20:57
MetLife Investment Management LLC Acquires 1,471 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
MetLife Investment Management LLC grew its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 5.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 27,883 shares of the company’s stock after purchasing an additional 1,471 shares during the quarter. MetLife Investment Management LLC’s holdings in Pacira BioSciences were worth $525,000 as of […] - 2025-05-06 05:01:05
Marshall Wace LLP Has $803,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Marshall Wace LLP lessened its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 91.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 42,613 shares of the company’s stock after selling 482,336 shares during the period. Marshall Wace LLP’s holdings in […] - 2025-05-01 04:50:59
Legal & General Group Plc Sells 1,115 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
Legal & General Group Plc decreased its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 0.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 125,849 shares of the company’s stock after selling 1,115 shares during the period. […] - 2025-04-25 05:08:57
Pacira BioSciences Announces Repurchase Authorization
(RTTNews) - Pacira BioSciences (PCRX) said its Board of Directors has authorized a share repurchase program of up to an aggregate of $300 million with respect to the common stock, replacing the prior authorization. The share repurchase authorization expires at the end of December - 2025-04-18 04:29:04
Sei Investments Co. Has $281,000 Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Sei Investments Co. trimmed its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 32.6% in the fourth quarter, HoldingsChannel reports. The firm owned 14,927 shares of the company’s stock after selling 7,231 shares during the period. Sei Investments Co.’s holdings in Pacira BioSciences were worth $281,000 as of its most recent SEC filing. […] - 2025-04-11 04:42:54
Wellington Management Group LLP Has $8.86 Million Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Wellington Management Group LLP lifted its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 3.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 470,191 shares of the company’s stock after purchasing an additional 15,542 shares during the quarter. Wellington Management Group LLP’s holdings in Pacira BioSciences were worth $8,858,000 […] - 2025-04-10 05:29:03
Pacira BioSciences (NASDAQ:PCRX) Shares Gap Up on Analyst Upgrade
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) gapped up prior to trading on Tuesday after HC Wainwright raised their price target on the stock from $48.00 to $65.00. The stock had previously closed at $22.91, but opened at $27.60. HC Wainwright currently has a buy rating on the stock. Pacira BioSciences shares last traded […] - 2025-04-10 02:24:54
Corebridge Financial Inc. Reduces Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Corebridge Financial Inc. lowered its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 7.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 24,412 shares of the company’s stock after selling 1,904 shares during the period. Corebridge Financial Inc.’s holdings in Pacira BioSciences were worth $460,000 as of its most recent filing […] - 2025-04-09 05:27:01
Arrowstreet Capital Limited Partnership Sells 505,307 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
Arrowstreet Capital Limited Partnership cut its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 43.8% during the 4th quarter, Holdings Channel.com reports. The fund owned 647,318 shares of the company’s stock after selling 505,307 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Pacira BioSciences were worth $12,195,000 as of […] - 2025-04-06 05:26:57
Thrivent Financial for Lutherans Has $672,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Thrivent Financial for Lutherans reduced its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 1.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 35,689 shares of the company’s stock after selling 534 shares during the period. Thrivent Financial for Lutherans’ holdings […] - 2025-04-03 04:16:46
Prudential Financial Inc. Decreases Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Prudential Financial Inc. reduced its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 42.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 254,168 shares of the company’s stock after selling 190,286 shares during the period. Prudential Financial Inc.’s holdings in Pacira BioSciences were worth $4,789,000 at the end of the most recent […] - 2025-04-01 05:34:48
Amundi Purchases 15,431 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
Amundi raised its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 200.8% in the 4th quarter, Holdings Channel reports. The firm owned 23,114 shares of the company’s stock after buying an additional 15,431 shares during the period. Amundi’s holdings in Pacira BioSciences were worth $429,000 at the end of the most recent quarter. […] - 2025-03-21 05:59:07
Victory Capital Management Inc. Reduces Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Victory Capital Management Inc. trimmed its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 22.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 94,750 shares of the company’s stock after selling 27,478 shares during the quarter. Victory Capital […] - 2025-03-18 05:41:07
Illinois Municipal Retirement Fund Has $383,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Illinois Municipal Retirement Fund reduced its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 29.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,307 shares of the company’s stock after selling 8,510 shares during the period. […] - 2025-03-05 08:01:50
Principal Financial Group Inc. Has $4.86 Million Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
Principal Financial Group Inc. boosted its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 4.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 257,733 shares of the company’s stock after buying an additional 10,306 shares during the quarter. Principal […] - 2025-03-04 06:14:50

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc PCRX holdings

DateNumber of PCRX Shares HeldBase Market Value of PCRX SharesLocal Market Value of PCRX SharesChange in PCRX Shares HeldChange in PCRX Base ValueCurrent Price per PCRX Share HeldPrevious Price per PCRX Share Held
2025-09-30 (Tuesday)6,385USD 164,541USD 164,541
2025-09-29 (Monday)6,345USD 160,782USD 160,782
2025-09-26 (Friday)6,345USD 160,148USD 160,148
2025-09-25 (Thursday)6,345USD 162,749PCRX holding decreased by -2538USD 162,7490USD -2,538 USD 25.65 USD 26.05
2025-09-24 (Wednesday)6,345USD 165,287USD 165,287
2025-09-17 (Wednesday)6,305USD 164,371PCRX holding decreased by -2775USD 164,3710USD -2,775 USD 26.0699 USD 26.5101
2025-09-16 (Tuesday)6,305USD 167,146USD 167,146
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of PCRX by Blackrock for IE00B3VWM098

Show aggregate share trades of PCRX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21SELL-20 25.390* 23.21 Profit of 464 on sale
2025-07-31BUY60 21.090* 23.21
2025-06-30SELL-40 23.900* 23.28 Profit of 931 on sale
2025-06-25SELL-20 23.910* 23.27 Profit of 465 on sale
2025-06-20SELL-40 24.230* 23.24 Profit of 930 on sale
2025-05-23BUY20 25.750* 22.89
2025-05-19SELL-20 26.150* 22.77 Profit of 455 on sale
2025-05-15SELL-60 25.600* 22.72 Profit of 1,363 on sale
2025-05-12SELL-20 25.090* 22.68 Profit of 454 on sale
2025-05-09SELL-20 25.120* 22.66 Profit of 453 on sale
2025-04-30SELL-20 26.900* 22.44 Profit of 449 on sale
2025-04-24SELL-40 26.000* 22.28 Profit of 891 on sale
2025-04-17SELL-20 24.650* 22.13 Profit of 443 on sale
2025-04-15SELL-60 24.880* 22.07 Profit of 1,324 on sale
2025-04-14SELL-60 24.970* 22.04 Profit of 1,322 on sale
2025-04-09SELL-80 25.840* 21.95 Profit of 1,756 on sale
2025-04-07SELL-140 22.910* 21.89 Profit of 3,065 on sale
2025-04-04SELL-200 23.100* 21.88 Profit of 4,375 on sale
2025-03-31BUY20 24.850* 21.78
2025-03-19SELL-40 24.280* 21.48 Profit of 859 on sale
2025-03-14SELL-120 22.870* 21.41 Profit of 2,569 on sale
2025-03-13SELL-40 22.690* 21.39 Profit of 856 on sale
2025-03-12SELL-680 22.040* 21.38 Profit of 14,540 on sale
2025-03-07SELL-40 23.370* 21.30 Profit of 852 on sale
2025-03-06SELL-60 23.860* 21.26 Profit of 1,276 on sale
2025-03-03SELL-20 22.960* 21.16 Profit of 423 on sale
2025-02-28SELL-120 24.050* 21.12 Profit of 2,534 on sale
2025-02-26SELL-20 25.480* 20.97 Profit of 419 on sale
2025-02-25SELL-60 25.100* 20.90 Profit of 1,254 on sale
2025-02-18BUY100 26.440* 20.35
2025-02-13BUY20 26.530* 20.02
2025-02-12BUY20 27.130* 19.88
2025-02-11BUY60 27.250* 19.72
2025-02-06BUY180 26.260* 19.30
2025-01-27BUY20 25.660* 17.81
2024-12-30BUY100 18.940* 17.39
2024-12-06BUY80 19.270* 17.19
2024-12-05BUY20 18.670* 17.14
2024-12-04BUY100 19.090* 17.07
2024-11-29BUY100 16.910* 17.06
2024-11-27BUY80 16.640* 17.10
2024-11-26BUY20 16.780* 17.11
2024-11-21BUY100 17.380* 17.06
2024-11-20BUY60 17.030* 17.06
2024-11-18BUY240 16.640* 17.11
2024-11-12BUY160 16.800* 17.13
2024-11-08BUY100 17.240* 17.12
2024-11-07BUY300 17.700* 17.07
2024-11-06BUY40 17.670* 17.02
2024-10-31BUY20 16.600* 17.17
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of PCRX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1952,0990123,26942.3%
2025-09-1843,5390107,41340.5%
2025-09-1754,1890246,30622.0%
2025-09-1682,4210239,73534.4%
2025-09-15159,0732307,67151.7%
2025-09-12205,2250267,65076.7%
2025-09-1180,5130176,03345.7%
2025-09-10116,5020171,70667.8%
2025-09-09112,4140188,83159.5%
2025-09-08105,2610236,75144.5%
2025-09-0575,5370131,84957.3%
2025-09-04149,7457,159289,31251.8%
2025-09-0397,2450200,54348.5%
2025-09-0275,5600288,06326.2%
2025-08-29110,3800181,05161.0%
2025-08-28205,3142,000326,73862.8%
2025-08-27195,9500334,50958.6%
2025-08-2680,1810135,86959.0%
2025-08-2565,9490124,99652.8%
2025-08-2249,7620102,73448.4%
2025-08-2180,8760126,10064.1%
2025-08-2056,3300101,29055.6%
2025-08-1975,7370218,36134.7%
2025-08-18152,6970401,06238.1%
2025-08-15125,6000367,48334.2%
2025-08-1493,3760314,28329.7%
2025-08-1366,5870288,60323.1%
2025-08-12131,60117215,99660.9%
2025-08-1187,1010177,37749.1%
2025-08-08318,2360459,60769.2%
2025-08-07223,1650394,08356.6%
2025-08-06500,5200674,65374.2%
2025-08-05136,3160282,39248.3%
2025-08-04240,6860344,05170.0%
2025-08-01450,6660517,52487.1%
2025-07-31124,4020322,81838.5%
2025-07-30121,8880287,26142.4%
2025-07-2944,574085,43252.2%
2025-07-2884,9170184,79946.0%
2025-07-25137,00743238,97457.3%
2025-07-2447,747098,60948.4%
2025-07-2348,1780113,46842.5%
2025-07-2266,2522,839149,87344.2%
2025-07-21111,7880294,45838.0%
2025-07-1899,442795177,71456.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.